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1. Introduction 
Plant lectins have been extensively employed as 
probes to study the chemical nature of the glycopro- 
teins of the cell surface of normal and malignant cells 
and for isolation and purification purposes [ 1,2]. The 
reactions with carbohydrate-containing polymers and 
serum glycoproteins have also been investigated and 
concanavalin A (con A), the Jack Bean lectin, which 
has a specific affinity for a-D-glucosyl residues and 
sterically related structures, has been found to bind 
and precipitate serum proteins including the acute 
phase reactants [3,4]. However, no attention has been 
paid to the value of lectin-serum glycoprotein inter- 
action for the assessment of the biological response 
to physiological, pathological and ‘pharmacological’ 
agents. 
Here we show that lectins and con A in particular 
can be employed as non-specific reagents in the assay 
of total serum glycoproteins. Almost alI the acute 
phase proteins such as orosomucoid, haptoglobin, 
cul-antitrypsin, cY1-antichymotrypsin and caerulo- 
plasmin whose concentration in serum increases in 
response to inflammation, tissue damage and malig- 
nant tumours [ 51 are glycoproteins and bind in vary- 
ing degree to con A and other lectins. Their measure- 
ment can be a useful aid in both the diagnosis and 
monitoring of certain inflammatory and neoplastic 
diseases, various glycoproteins being affected to a dif- 
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ferent degree in different conditions. We have studied 
the use of con A, Ricinus communis agglutinin (RCA) 
and Abrus precatorius lectin (ABL) as agents to mea- 
sure acute phase proteins in man and animals during 
inflammation. 
2. Materials and methods 
2.1. Nephelomeby 
The Hyland laser nephelometer PDQ system was 
used for the nephelometric assay of lectin binding. 
Con A reagent solution was made by dissolving 10 mg 
con A (Miles Labs., Slough) in 100 ml phosphate- 
buffered saline (pH 7.2) containing 30 g/l polyethylene 
glycol (mol. wt 6000). The parameters affecting this 
assay have been described [6]. ABL was used at 
1.2 mg/ 100 ml and RCA at 2 .O mg/ 100 ml (both were 
a gift from Dr T. Forrester of the Chester Beatty Res. 
Inst ., London). 
2.2. Laurel1 rocket electrophoresis 
The Laurel1 rocket technique [7] was used with a 
gel containing 0.1% (w/v) of lectin. 
2.3. Reference material 
A reference curve was prepared from a pooled 
human serum containing high levels of glycoproteins. 
Results were arbitrarily expressed as a % of this pool. 
2.4. The measurement of acute phase proteins 
All acute phase proteins were measured by the 
Laurel1 rocket technique [7] using antisera obtained 
from Seward Labs., Birmingham. 
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3. Results and discussion 
We have measured the binding of con A., ABL and 
RCA to human serum glycoproteins by iaser nephelo- 
metry and Laurel1 rockets, and have been able to show 
that this reaction can be used to quantitate changes 
in acute phase proteins (fig.1). As the method is based 
on the precipitation of protein by the reaction with 
the sugar residue and not with the species-specific 
protein part of the molecule the assay can be per- 
formed on any animal species. The dilution curves 
from human and animal sera both in normal and 
pathological conditions are parallel in spite of the 
presence of a mixture of glycoproteins varying in 
nature and amount (table 1). 
We have found this assay to have similar value to 
individual protein measurements for monitoring 
disease in man. Cats, dogs and horses with inflam- 
matory disease, and rats with experimentally-induced 
inflammation, show higher levels of con A binding 
than do normal animals (fig.2,3); this measurement 
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Table 1 
Values obtained by assaying dilutions of sera from individuals 
with inflammation against a human serum pool for con A 
binding proteins 
Serum Con A binding as % of serum standard 
serum dilutions 
Neat 112 l/4 l/8 
Human A 87 81 82 86 
Human B 61 59 58 60 
Human C 61 62 64 72 
Horse - 109 100 96 
Cat 18 79 80 80 
has proved diagnostically useful in animals with non- 
specific signs of illness. 
Species-specific antisera to acute phase proteins are 
not widely available and protein analyses in animals 
have been rather neglected. L&in-binding assays 
should therefore prove extremely valuable as a much 
I B +40 
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Fig.1. Sequential changes in lectin binding by and acute phase proteins in the serum of a patient with rheumatoid arthritis. (A) 
Lectin binding measured nephelometrically. (B) Acute phase proteins measured by rocket electrophoresis. AAT, qantitrypsin; 
ACT, a,-antichymotrypsin; CRP, c-reactive protein; HPT, haptoglobin. Con A binding integrates the changes in several acute phase 
proteins. Note that at 5 weeks con A binding has been suppressed by the falling level of AAT, a protein to which it binds strongly, 
whereas that of RCA has not. ABL reacts predominantly with HPT and hence shows a very similar pattern to that of this protein. 
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Fig.2. Con A binding in normal animals and animals with 
inflammatory disease. The inflammatory diseases were pre- 
dominantly due to infection though some were immune com- 
plex or auto-immune in origin. 
needed index of inflammation for evaluating the effect 
of both inflammatory and anti-inflammatory agents 
in the experimental animal. In veterinary practice we 
have found them to be of value in the diagnosis and 
management of inflammatory disease. 
The lectin nephelometric and Laurel1 rocket assays 
are rapid, precise (CV 5%) and inexpensive. The 
nephelometric assays may also be automated. Unlike 
the erythrocyte sedimentation rate they are generally 
applicable; they may be performed on serum or plasma 
samples that have been frozen and require as little as 
5 1.11 sample. In addition, con A has the advantage of 
being a single, relatively inexpensive, easily-charac- 
terised reagent of known specificity without the vaga- 
ries to which antiserum production is prone. The use 
of various lectins combining with different sugars 
may provide a means of identifying and measuring 
specific glycoproteins, and may also be applied fol- 
lowing established separation methods, e.g., electro- 
phoresis or chromatography. Using immunofuration 
techniques, certain characteristic patterns have already 
been observed in animals and it has been possible to 
demonstrate and identify the presence of carbohydrate 
moieties in a variety of biological materials. 
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Fig. 3. Sequential changes in con A binding in the plasma of 6 rats with adjuvant-induced arthritis. The initial sharp rise is associated 
with local inflammation at the site of injection of Freund’s adjuvant. The increase at 14 days is associated with arthritis. Pre-treat- 
ment: X, 80.5, SD 8.7; 1 day X 130, SD 18.2; 7 days I 113, SD 17.5; 14 days X 137, SD 15.1; 21 days X 126, SD 13.3. 
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